A miR-125b binding site polymorphism in bone morphogenetic protein membrane receptor type IB gene and prostate cancer risk in China
- 10 May 2011
- journal article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 39 (1) , 369-373
Abstract
Recently, a C>T polymorphism (rs1434536) in a miR-125b binding site in the 3′ untranslated region (3′UTR) of bone morphogenetic protein membrane receptor type IB gene (BMPR1B) has been found to contribute to cancer susceptibility. To investigate whether it plays an important role in the development of prostate cancer in southern Chinese Han population, we performed a case–control study. 247 prostate cancer and 278 control subjects were included in the cancer association study and dual-luciferase reporter assay was used to test the binding ability of miR-125b to BMPR1B-C or -T vectors. The effect of CT/TT genotype on prostate cancer risk was found to be significant for localized disease (OR = 1.60, 95% CI = 1.01–2.53, P = 0.044) and among subgroups of aged >70 years (OR = 1.90, 95% CI = 1.15–3.15, P = 0.015) compared with CC genotype. Moreover, C-allele gave a reduced luciferase activity relative to T-allele in dual-luciferase reporter assay. Our findings show that rs1434536 in the 3′UTR of BMPR1B gene affects the binding ability of miR-125b to BMPR1B mRNA and contributes to the genetic predisposition to localized prostate cancer and patients aged >70 years.Keywords
This publication has 19 references indexed in Scilit:
- Regulation of melanin synthesis by the TGF-β family in B16 melanoma cellsMolecular Biology Reports, 2008
- Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancerCarcinogenesis, 2007
- The role of site accessibility in microRNA target recognitionNature Genetics, 2007
- MicroRNA and cancer: Current status and prospectiveInternational Journal of Cancer, 2006
- The Diverse Functions of MicroRNAs in Animal Development and DiseaseDevelopmental Cell, 2006
- The functions of animal microRNAsNature, 2004
- A high-throughput method to monitor the expression of microRNA precursorsNucleic Acids Research, 2004
- Expression of bone morphogenetic protein receptors type-IA, -IB and -II correlates with tumor grade in human prostate cancer tissues.2000
- Bone morphogenetic protein-2 but not bone morphogenetic protein-4 and -6 stimulates chemotactic migration of human osteoblasts, human marrow osteoblasts, and U2-OS cellsBone, 1996
- Novel Regulators of Bone Formation: Molecular Clones and ActivitiesScience, 1988